Search results for “Testosterone deficiency” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 231 patents, we discovered top 29 key players by total patent application. Clarus Therapeutics, Inc., Lipocine, Inc., TOLMAR, Inc. are dominant in this area. They take 35.50% of the total patent filing.
Clarus Therapeutics, Inc.
Illinois, United States
Patent: 37
Lipocine, Inc.
Utah, United States
Patent: 24
TOLMAR, Inc.
Colorado, United States
Patent: 21
Acerus Biopharma Inc
United States
Patent: 21
Professional Compounding Centers of America, Inc.
Texas, United States
Patent: 19
Repros Therapeutics, Inc.
Texas, United States
Patent: 18
Jenapharm GmbH & Co. KG
Thüringen, Germany
Patent: 10
Acerus Pharmaceuticals Corp.
Ontario, Canada
Patent: 9
Chong Kun Dang Pharmaceutical Corp.
South Korea
Patent: 7
Pfizer Products, Inc.
Connecticut, United States
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 47 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing TOLMAR, Inc., Chong Kun Dang Pharmaceutical Corp., Acerus Biopharma Inc take 55.32% of patent filing during this period.
TOLMAR, Inc.
Colorado, United States
Patent: 12
Chong Kun Dang Pharmaceutical Corp.
South Korea
Patent: 7
Acerus Biopharma Inc
United States
Patent: 7
Lipocine, Inc.
Utah, United States
Patent: 4
Clarus Therapeutics, Inc.
Illinois, United States
Patent: 3
Acerus Pharmaceuticals Corp.
Ontario, Canada
Patent: 3
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 2
Baiyuete Biotechnology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 1
Professional Compounding Centers of America, Inc.
Texas, United States
Patent: 1
Guangdong Medical University
Guangdong Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 47 patents in last 5 years, we discover 8 new entrants. Chong Kun Dang Pharmaceutical Corp., Sun Yat-Sen University, Baiyuete Biotechnology (Shanghai) Co., Ltd. are the most active new entrants in this area.
Chong Kun Dang Pharmaceutical Corp.
South Korea
Patent: 7
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 2
Baiyuete Biotechnology (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 1
University of Washington
Washington, United States
Patent: 1
Zhanjiang Guangyi Asset Management Co., Ltd.
Guangdong Sheng, China
Patent: 1
Guangdong Medical University
Guangdong Sheng, China
Patent: 1
The Second Affiliated Hospital of Wenzhou Medical University (Yuying Children's Hospital of Wenzhou Medical University)
undefined undefined
Patent: 1
Chong Kun Dang Corp
South Korea
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 13 patents, we discovered top 5 universities and scientific research institutions by total patent application. Sun Yat-Sen University, Western University of Health Sciences, University of Washington are dominant in this area. They take 38.46% of the total patent filing.
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 2
Western University of Health Sciences
California, United States
Patent: 2
University of Washington
Washington, United States
Patent: 1
Jinan University
Guangdong Sheng, China
Patent: 1
Guangdong Medical University
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: